Home / Business and Economy / Ajanta Pharma Sees Sales Surge 20%, Profit Jumps 18%
Ajanta Pharma Sees Sales Surge 20%, Profit Jumps 18%
30 Jan
Summary
- Ajanta Pharma's net profit grew 17.56% to Rs 273.77 crore in December 2025.
- Sales increased by 19.95% to Rs 1374.84 crore during the same quarter.
- The company maintained strong operational performance with a steady OPM.
Ajanta Pharma reported robust financial results for the quarter ending December 2025. The pharmaceutical company's net profit experienced a notable increase of 17.56%, rising to Rs 273.77 crore from Rs 232.88 crore recorded in the December 2024 quarter. This enhanced profitability was driven by a significant 19.95% surge in sales.
During the December 2025 quarter, sales reached Rs 1374.84 crore, a substantial rise from Rs 1146.13 crore in the prior-year period. The company demonstrated operational efficiency, with its profit before depreciation and tax (PBDT) increasing by 17% and profit before tax (PBT) also growing by 17%. The operating profit margin (OPM) remained remarkably stable at 27.80% in the latest quarter, compared to 27.99% in the previous year.
